Pembrolizumab Cutaneous Adverse Events and Their Association With Disease ProgressionMartina Sanlorenzo, Susana Ortiz‐Urda, Matthew A. Gubens et al.|JAMA Dermatology|2015Cited by 452
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)Luca Borradori, Gang Wang, Nina van Beek et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 247